The global transplantation market size reached US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8.39% during 2024-2032. The increasing number of organ failures, the surging prevalence of lifestyle disorders, and rising public awareness about advancements in medical technology represent some of the key factors driving the market.
Market Size in 2023
|US$ 16.0 Billion
Market Forecast in 2032
|US$ 33.6 Billion
|Market Growth Rate 2024-2032
Transplantation is a medical procedure wherein tissues, human cells or an organ is transferred from the body of a donor to the recipient. It is required when the organ or tissues of an individual becomes damaged by a disease and an injury. It generally involves a diagnostic procedure that is performed pre- and post-surgery. It helps recover tissues, such as blood vessels, bone, cartilage, corneas, heart valves, skin, and tendons. It also aids in recovering organs, including the heart, intestine, kidney, liver, lung, and pancreas. At present, the increasing awareness among individuals about treatments, including stem cell and bone marrow transplantation, is catalyzing the demand for transplantation across the globe.
Transplantation Market Trends:
There is currently a surge in the prevalence of various chronic diseases, such as cancer and diabetes, leukemia, lymphoma, sickle cell anemia, osteoporosis, Alzheimer's disease, and chronic obstructive pulmonary disease (COPD). This, coupled with the increasing geriatric population, which is more prone to develop severe medical conditions, represents one of the major factors driving the demand for transplantation around the world. Moreover, there is a rise in the number of organ failures due to the loss of blood, severe trauma, drug abuse, sepsis, and other acute diseases. This, coupled with the growing occurrence of lifestyle disorders on account of unhealthy dietary habits, smoking, alcohol consumption, and a sedentary lifestyle, is influencing the demand for transplantation. In addition, the rising number of fatal road accidents leading to severe injuries is catalyzing the demand for transplantation worldwide. Apart from this, the increasing public awareness about advancements in medical technology and a shortage in the number of organ donors are contributing to the market growth. Furthermore, the introduction of advanced techniques, such as three-dimensional (3D) bioprinting, decellularization and recellularization, and interspecies organogenesis to overcome immunologic hurdles, is favoring the growth of the market. Additionally, there is an increase in the number of tissue banks for minimizing the risk of bacterial and fungal infections of tissues by using aseptic surgical techniques and processing and storing the tissue from the donor. Besides this, significant improvements in diagnostic technologies and healthcare infrastructure are expected to provide a favorable market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global transplantation market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, application, and end user.
- Tissue Products
- Immunosuppressive Drugs
- Preservation Solution
The report has provided a detailed breakup and analysis of the transplantation market based on the product. This includes tissue products, immunosuppressive drugs, and preservation solution. According to the report, tissue products represented the largest segment.
- Organ Transplantation
- Tissue Transplantation
A detailed breakup and analysis of the transplantation market based on the application has also been provided in the report. This includes organ transplantation and tissue transplantation. According to the report, tissue transplantation accounted for the largest market share.
End User Insights:
- Transplantation Centers
The report has provided a detailed breakup and analysis of the transplantation market based on the end user. This includes hospitals, transplantation centers, and others. According to the report, hospitals represented the largest segment.
- North America
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for transplantation. Some of the factors driving the North America transplantation market included the increasing number of organ failures, advanced technologies, the presence of well-established healthcare infrastructure and improved diagnostic technologies, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global transplantation market. Detailed profiles of all major companies have also been provided. Some of the companies covered include 21st Century Medicine, AbbVie Inc., Arthrex Inc., Astellas Pharma Inc., BioLife Solutions Inc., CareDx Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., TransMedics Inc., Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Base Year of the Analysis
||Tissue Products, Immunosuppressive Drugs, Preservation Solution
||Organ Transplantation, Tissue Transplantation
|End Users Covered
||Hospitals, Transplantation Centers, Others
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||21st Century Medicine, AbbVie Inc., Arthrex Inc., Astellas Pharma Inc., BioLife Solutions Inc., CareDx Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., TransMedics Inc., Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation), etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the transplantation market from 2018-2032.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global transplantation market.
- The study maps the leading as well as the fastest growing regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the transplantation industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.